The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review-Reference-Cited by-同舟云学术

The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review

Published:2018-06-22 Issue:10 Volume:14 Page:1313-1333
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Hansson Oskar¹²,Mikulskis Alvydas³,Fagan Anne M.⁴,Teunissen Charlotte⁵,Zetterberg Henrik⁶⁷⁸⁹,Vanderstichele Hugo¹⁰,Molinuevo Jose Luis¹¹,Shaw Leslie M.¹²,Vandijck Manu¹³,Verbeek Marcel M.¹⁴,Savage Mary¹⁵,Mattsson Niklas¹,Lewczuk Piotr¹⁶¹⁷,Batrla Richard¹⁸,Rutz Sandra¹⁹,Dean Robert A.²⁰,Blennow Kaj⁸⁹

Affiliation:

1. Department of NeurologySkåne University HospitalLundSweden

2. Memory ClinicSkåne University HospitalMalmöSweden

3. BiogenBostonMAUSA

4. Department of NeurologyWashington University School of MedicineSt LouisMOUSA

5. VU University Medical CenterAmsterdamThe Netherlands

6. UK Dementia Research InstituteLondonUK

7. Department of Molecular NeuroscienceUCL Institute of NeurologyLondonUK

8. Clinical Neurochemistry LaboratorySahlgrenska University HospitalMölndalSweden

9. Department of Psychiatry and NeurochemistrySahlgrenska Academy at the University of GothenburgMölndalSweden

10. ADx NeuroSciencesGentBelgium

11. BarcelonaBeta Brain Research CenterPasqual Maragall FoundationBarcelonaSpain

12. Department of Pathology and Laboratory MedicinePerelman School of MedicineUniversity of PennsylvaniaPhiladelphiaPAUSA

13. Fujirebio‐Europe NVGentBelgium

14. Radboud University Medical CenterDepartments of Neurology and Laboratory MedicineDonders Institute for BrainCognition and BehaviourNijmegenThe Netherlands

15. Merck and CompanyWest PointPAUSA

16. Department of Psychiatry and PsychotherapyUniversitätsklinikum ErlangenFriedrich‐Alexander Universität Erlangen‐NürnbergGermany

17. Department of Neurodegeneration DiagnosticsMedical University of BialystokPoland

18. Roche Diagnostics GmbHRotkreuzSwitzerland

19. Roche Diagnostics GmbHPenzbergGermany

20. Department of Pathology and Laboratory MedicineIndiana University School of MedicineIndianapolisINUSA

Funder

Alzheimer's Disease Neuroimaging Initiative

Eli Lilly and Company

Roche

Vetenskapsrådet

Hjärnfonden

Seventh Framework Programme

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2018.05.008

Reference156 articles.

1. Introduction to the recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

2. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

3. CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment

4. The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials

5. Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical significance of plasma candidate biomarkers of Alzheimer’s Disease;Neurologia i Neurochirurgia Polska;2024-08-28

2. Hematopoietic stem cell transplantation or enzyme replacement therapy in Gaucher disease type 3;Molecular Genetics and Metabolism;2024-08

3. Advances in Blood Biomarkers for Alzheimer’s Disease: Ultra-Sensitive Detection Technologies and Impact on Clinical Diagnosis;Degenerative Neurological and Neuromuscular Disease;2024-07

4. Effects of time of the day at sampling on CSF and plasma levels of Alzheimer’ disease biomarkers;Alzheimer's Research & Therapy;2024-06-22

5. Relationship Between Cerebrospinal Fluid Alzheimer’s Disease Biomarker Values Measured via Lumipulse Assays and Conventional ELISA: Single-Center Experience and Systematic Review;Journal of Alzheimer's Disease;2024-05-28